期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 30, 期 12, 页码 974-989出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2019.09.004
关键词
-
资金
- National Institute of Diabetes and Digestive and Kidney Diseases [R43DK115277]
- National Cancer Institute [R01CA212609]
- Purdue University's College of Agriculture
The global rise in the prevalence of obesity and affiliated metabolic syndrome poses a significant threat to human health. Various approaches, including bariatric surgery and pharmacotherapy, have been used in the clinical setting for obesity treatment; however, these conventional options remain ineffective and carry risks of adverse effects. Therefore, treatments with higher efficacy and specificity are urgently required. Emerging drug delivery systems use polymeric materials and chemical strategies to improve therapeutic efficacy and specificity through stabilizatior and spatiotemporally controlled release of antiobesity agents. In this review, we provide in sights into current treatments for obesity with a focus on recent developments of polymeric car riers for enhanced antiobesity drug delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据